Su Han Lum, Michael H Albert, Patrick Gilbert, Tiarlan Sirait, Mattia Algeri, Rafaella Muratori, Benjamin Fournier, Alexandra Laberko, Musa Karakukcu, Ekrem Unal, Mouhab F Ayas, Satya Prakash Yadav, Tunc Fisgin, Reem Elfeky, Juliana Folloni Fernandes, Maura Faraci, Theresa Cole, Ansgar S Schulz, Roland Meisel, Marco Zecca, Marianne Ifversen, Alessandra Biffi, Jean-Sebastien Diana, Tanja C Vallée, Stefano Giardino, Gizem Zengin Ersoy, Despina Moshous, Andrew R Gennery, Dmitry Balashov, Carmem M S Bonfim, Franco Locatelli, Arjan C Lankester, Bénédicte Neven, Mary A Slatter
HLA-mismatched transplants with either in vitro depletion of CD3+TCRαβ/CD19 (TCRαβ) cells or in vivo T-cell depletion using post-transplant cyclophosphamide (PTCY) have been increasingly used for patients with inborn errors of immunity (IEI). We performed a retrospective multicenter study via the EBMT registry on 306 children with IEI undergoing first transplant between 2010-2019 from an HLA-mismatched donor using TCRαβ (n=167) or PTCY (n=139). Median age at HSCT was 1.2 years (range, 0...
April 26, 2024: Blood